SCHEMBL14725745

SCHEMBL14725745

c1ccc(-c2cc3cc4c(cc(-c5ccccc5)c5cc6c(cc54)sc4ccccc46)cc3c3cc4sc5ccccc5c4cc23)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.45
MAPT P10636 5/20 0.42
ALDH1A1 P00352 3/20 0.42
HPGD P15428 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
RAB9A P51151 1/20 0.42
POLB P06746 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
MPI P34949 1/20 0.38
KMT2A Q03164 1/20 0.38
TNKS O95271 1/20 0.37
TNKS2 Q9H2K2 1/20 0.37
F9 P00740 1/20 0.37
ALOX5 P09917 1/20 0.37
CYP1A2 P05177 1/20 0.36
PTPN7 P35236 1/20 0.35
DUSP3 P51452 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21180620 0.92 GPR3 (0.44) GPR3MAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL14725769 0.89 GPR3 (0.44) GPR3MAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL14725617 0.87 GPR3 (0.37) GPR3MAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL14725749 0.86 RAB9A (0.39) GPR3MAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL16472914 0.84 GPR3 (0.37) GPR3MAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL15461832 0.84 GPR3 (0.37) GPR3MAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL14725755 0.84 CYP11B1 (0.55) GPR3RAB9AALOX5
SCHEMBL14727526 0.84 NPC1 (0.48) MAPTALDH1A1HPGDSMN1; SMN2RAB9A
SCHEMBL14725747 0.84 CYP11B1 (0.48) ALDH1A1RAB9ACYP1A2
SCHEMBL22155624 0.83 ALDH1A1 (0.40) GPR3MAPTALDH1A1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9255084-B2 Heterocyclic compound and organic light-emitting device containing the same SAMSUNG DISPLAY CO., LTD. (KR) 2016-02-09 US disclosed
US-20130048955-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2013-02-28 US disclosed
US-20130048955-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2013-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130048955-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME TRPC1, TRPC4, TRPC6 GPR3 3596/4885MAPT 717/4885ALDH1A1 813/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.